Last Updated on February 19, 2021 by The Health Master
Dr Reddy’s Laboratories Ltd announced the launch of the US Food and Drug Administration (USFDA) approved fluphenazine hydrochloride tablets, USP.
This is a therapeutic equivalent generic version of Prolixin tablets, 1 mg, 2.5 mg, 5 mg, and 10 mg.
The Prolixin brand and generic had US sales of approximately $134 million MAT for the most recent twelve months ending in December 2020 according to IQVIA Health.
Dr Reddy’s fluphenazine hydrochloride tablets, USP are available in 1 mg, 2.5 mg, 5 mg, and 10 mg tablets in 100 bottle count sizes.
Also read:
Lupin launches Posaconazole Delayed-Release Tablets
Glenmark launches Kidney drug at 96% lower price
Lupin, Aurobindo units recall medicines in US market
Alembic gets USFDA final nod for Treprostinil injection
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
Go to main website, click here
Follow and connect with us on Facebook and Linkedin
Subscribe for daily free updates, click here
For daily free updates on WhatsApp, click here
